BiotechTube

Nexium 20mg + Nexium 10mg

Phase 3Recruiting
0 views this week 0 watching⚡ Active
Interest: 47/100
47
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Erosive Esophagitis

Conditions

Erosive Esophagitis

Trial Timeline

Jul 1, 2022 → Sep 6, 2027

NCT ID
NCT05267613

About Nexium 20mg + Nexium 10mg

Nexium 20mg + Nexium 10mg is a phase 3 stage product being developed by AstraZeneca for Erosive Esophagitis. The current trial status is recruiting. This product is registered under clinical trial identifier NCT05267613. Target conditions include Erosive Esophagitis.

What happened to similar drugs?

6 of 12 similar drugs in Erosive Esophagitis were approved

Approved (6) Terminated (0) Active (6)
✅Teprenone capsule and placebo of sucralfate + Sucralfate and placebo of teprenoneEisaiApproved
✅Esomeprazole + LansoprazoleAstraZenecaApproved
✅Esomeprazole + LansoprazoleAstraZenecaApproved
✅Esomeprazole + EsomeprazoleAstraZenecaApproved
✅esomeprazole magnesium (oral medication)AstraZenecaApproved
✅Omeprazole/sodium bicarbonateBausch HealthApproved
🔄E3810 + E3810 + PlaceboEisaiPhase 3

Hype Score Breakdown

Clinical
17
Activity
15
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT05267613Phase 3Recruiting

Competing Products

20 competing products in Erosive Esophagitis

See all competitors
ProductCompanyStageHype Score
YH1885L(Revaprazan) + Esomeprazole 20mg + placeboYuhanPhase 2
35
E3810 + E3810 + PlaceboEisaiPhase 3
40
RABEPRAZOLE SODIUM + RABEPRAZOLE SODIUMEisaiPhase 3
40
Teprenone capsule and placebo of sucralfate + Sucralfate and placebo of teprenoneEisaiApproved
43
ABT-981 + Placebo for ABT-981AbbViePhase 2
35
OmeprazoleAstraZenecaPhase 3
40
Esomeprazole + LansoprazoleAstraZenecaApproved
43
OmeprazoleAstraZenecaPhase 3
40
AZD0865AstraZenecaPhase 2
35
Esomeprazole + LansoprazoleAstraZenecaApproved
43
Esomeprazole + EsomeprazoleAstraZenecaApproved
43
AZD0865AstraZenecaPhase 2
35
esomeprazole magnesium (oral medication)AstraZenecaApproved
43
Alendronate Effervescent Oral TabletAmgenPhase 2
35
Omeprazole/sodium bicarbonateBausch HealthApproved
37
VonoprazanPhathom PharmaceuticalsPhase 1
23
Vonoprazan + LansoprazolePhathom PharmaceuticalsPhase 3
34
Vonoprazan + PlaceboPhathom PharmaceuticalsPhase 2
29
VonoprazanPhathom PharmaceuticalsPre-clinical
27
Vonoprazan + PlaceboPhathom PharmaceuticalsPhase 3
34